ORAL-CONTRACEPTIVE USE AND MALIGNANT-MELANOMA IN AUSTRALIA

被引：68

作者：

BERAL, V ^{[1
]}

EVANS, S ^{[1
]}

SHAW, H ^{[1
]}

MILTON, G ^{[1
]}

机构：

[1] UNIV SYDNEY,DEPT SURG,SYDNEY,NSW 2007,AUSTRALIA

来源：

关键词：

D O I：

10.1038/bjc.1984.236

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：681 / 685

页数：5

共 9 条

[1] A CASE-CONTROL STUDY OF THE POSSIBLE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVES AND MALIGNANT-MELANOMA
ADAM, SA
SHEAVES, JK
WRIGHT, NH
MOSSER, G
HARRIS, RW
VESSEY, MP
[J]. BRITISH JOURNAL OF CANCER, 1981, 44 (01) : 45 - 50
[2] BAIN C, 1982, J NATL CANCER I, V68, P537
[3] CUTANEOUS FACTORS RELATED TO THE RISK OF MALIGNANT-MELANOMA
BERAL, V
EVANS, S
SHAW, H
MILTON, G
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1983, 109 (02) : 165 - 172
[4] BERAL V, 1982, LANCET, V2, P290
[5] MALIGNANT-MELANOMA AND ORAL-CONTRACEPTIVE USE AMONG WOMEN IN CALIFORNIA
BERAL, V
RAMCHARAN, S
FARIS, R
[J]. BRITISH JOURNAL OF CANCER, 1977, 36 (06) : 804 - 809
[6] HOLLY EA, 1983, JNCI-J NATL CANCER I, V70, P827
[7] MALIGNANT-MELANOMA AND ORAL-CONTRACEPTIVES
KAY, CR
[J]. BRITISH JOURNAL OF CANCER, 1981, 44 (03) : 479 - 479
[8] RAMCHARAN S, 1981, WALNUT CREEK CONTRAC, V3
[9] ROTHMAN KJ, 1979, DHEW1NIH791649 PUBL